These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 10886725)
1. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Chang MS; Lee JH; Kim JP; Kim HS; Lee HS; Kim CW; Kim YI; Kim WH Pathol Int; 2000 Jun; 50(6):486-92. PubMed ID: 10886725 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. Kaizaki Y; Hosokawa O; Sakurai S; Fukayama M J Gastroenterol; 2005 Jun; 40(6):570-7. PubMed ID: 16007390 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135 [TBL] [Abstract][Full Text] [Related]
5. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases. Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. Chang MS; Kim HS; Kim CW; Kim YI; Lan Lee B; Kim WH Hum Pathol; 2002 Apr; 33(4):415-20. PubMed ID: 12055676 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China. Liu S; Zhao Z; Han L; Liu S; Luo B PLoS One; 2016; 11(2):e0148342. PubMed ID: 26859565 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477 [TBL] [Abstract][Full Text] [Related]
13. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer. Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232 [TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal. Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476 [TBL] [Abstract][Full Text] [Related]
15. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Chang MS; Lee HS; Kim CW; Kim YI; Kim WH Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Chang MS; Kim WH; Kim CW; Kim YI Histopathology; 2000 Oct; 37(4):309-15. PubMed ID: 11012737 [TBL] [Abstract][Full Text] [Related]
18. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601 [TBL] [Abstract][Full Text] [Related]